Segall Bryant & Hamill LLC increased its holdings in shares of Innophos Holdings, Inc. (NASDAQ:IPHS) by 2.6% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,119,006 shares of the specialty chemicals company’s stock after acquiring an additional 28,699 shares during the quarter. Innophos comprises 0.8% of Segall Bryant & Hamill LLC’s investment portfolio, making the stock its 21st biggest position. Segall Bryant & Hamill LLC owned about 5.71% of Innophos worth $53,265,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Thomson Horstmann & Bryant Inc. boosted its holdings in Innophos by 8.4% in the 1st quarter. Thomson Horstmann & Bryant Inc. now owns 20,366 shares of the specialty chemicals company’s stock valued at $818,000 after purchasing an additional 1,570 shares during the last quarter. Swiss National Bank boosted its holdings in Innophos by 6.3% in the 1st quarter. Swiss National Bank now owns 34,000 shares of the specialty chemicals company’s stock valued at $1,367,000 after purchasing an additional 2,000 shares during the last quarter. Nisa Investment Advisors LLC boosted its holdings in Innophos by 66.9% in the 2nd quarter. Nisa Investment Advisors LLC now owns 6,235 shares of the specialty chemicals company’s stock valued at $297,000 after purchasing an additional 2,500 shares during the last quarter. Principal Financial Group Inc. boosted its holdings in Innophos by 2.2% in the 1st quarter. Principal Financial Group Inc. now owns 154,499 shares of the specialty chemicals company’s stock valued at $6,212,000 after purchasing an additional 3,268 shares during the last quarter. Finally, Confluence Investment Management LLC boosted its holdings in Innophos by 3.4% in the 2nd quarter. Confluence Investment Management LLC now owns 105,457 shares of the specialty chemicals company’s stock valued at $5,020,000 after purchasing an additional 3,463 shares during the last quarter. Hedge funds and other institutional investors own 95.73% of the company’s stock.

Several equities analysts have weighed in on the stock. BidaskClub upgraded shares of Innophos from a “strong sell” rating to a “sell” rating in a report on Tuesday, April 24th. Zacks Investment Research upgraded shares of Innophos from a “sell” rating to a “hold” rating in a report on Wednesday, April 25th. Finally, TheStreet upgraded shares of Innophos from a “c+” rating to a “b” rating in a report on Wednesday, May 30th.

NASDAQ:IPHS traded down $0.06 on Friday, hitting $43.57. The stock had a trading volume of 2,668 shares, compared to its average volume of 110,591. The company has a debt-to-equity ratio of 0.99, a current ratio of 2.75 and a quick ratio of 1.34. The firm has a market capitalization of $863.75 million, a price-to-earnings ratio of 17.71 and a beta of 0.74. Innophos Holdings, Inc. has a 1-year low of $38.66 and a 1-year high of $51.34.

Innophos (NASDAQ:IPHS) last released its quarterly earnings results on Monday, July 30th. The specialty chemicals company reported $0.55 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.65 by ($0.10). The company had revenue of $206.73 million during the quarter, compared to analysts’ expectations of $213.40 million. Innophos had a net margin of 2.21% and a return on equity of 14.28%. Innophos’s revenue was up 15.4% on a year-over-year basis. During the same period last year, the firm posted $0.57 earnings per share. equities analysts anticipate that Innophos Holdings, Inc. will post 2.79 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 5th. Stockholders of record on Friday, August 17th will be paid a $0.48 dividend. This represents a $1.92 dividend on an annualized basis and a dividend yield of 4.41%. The ex-dividend date is Thursday, August 16th. Innophos’s dividend payout ratio (DPR) is 78.05%.

About Innophos

Innophos Holdings, Inc, together with its subsidiaries, produces specialty ingredients with applications in food, health, nutrition, and industrial markets. It operates through three segments: Food, Health and Nutrition; Industrial Specialties; and Other. The company's specialty ingredients include specialty phosphate salts and specialty phosphoric acids, as well as other mineral, enzyme, and botanical based specialty ingredients that are used as flavor enhancers in beverages; electrolytes in sports drinks; texture modifiers in cheeses; leavening agents in baked goods; calcium and phosphorus fortification in food and beverages; moisture and color retention in seafood, poultry, and meat; excipients in vitamins, minerals, nutritional supplements, and pharmaceuticals; and abrasives in toothpaste.

Further Reading: How Do I Invest in Dividend Stocks

Want to see what other hedge funds are holding IPHS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innophos Holdings, Inc. (NASDAQ:IPHS).

Institutional Ownership by Quarter for Innophos (NASDAQ:IPHS)

Receive News & Ratings for Innophos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos and related companies with MarketBeat.com's FREE daily email newsletter.